Investors Alert: LifeMD, Inc. Faces Securities Fraud Class Action Lawsuit

LifeMD, Inc. Faces Securities Fraud Class Action Lawsuit

LifeMD, Inc., publicly traded under the NASDAQ symbol LFMD, is currently dealing with a class action lawsuit filed by Levi & Korsinsky, LLP. This lawsuit pertains to alleged fraudulent activities that adversely impacted investors between May 7, 2025, and August 5, 2025. Investors are urged to take action, as the deadline to become involved in the case approaches on October 25, 2025.

Class Action Overview

The legal complaint asserts that LifeMD, Inc.'s executives made misleading statements and failed to disclose vital information regarding the company's competitive status. The lawsuit centers on allegations that the defendants overstated LifeMD's competitive position. Moreover, there are claims suggesting that the company mismanaged its financial outlook for 2025, failing to account for rising customer acquisition costs related to its RexMD segment and for medicines like Wegovy and Zepbound intended for obesity treatment. These misrepresentations, according to the filing, rendered the company's statements about its business and prospects materially false and misleading.

What Investors Need to Know

Investors who have experienced losses during the specified time frame may join the lawsuit and possibly recover damages. They do not need to serve as lead plaintiffs to share in any recovery benefits. Participating in the class action comes at no cost to the class members, as all associated legal fees will be handled by Levi & Korsinsky, ensuring that investors can seek compensation without out-of-pocket expenses.

Next Steps for Investors

For those impacted or interested in the lawsuit, Levi & Korsinsky has set up multiple avenues for potential claimants to engage with their legal team. Investors can visit their dedicated link to gain more information on the lawsuit: Class Action Submission. Furthermore, those who prefer direct contact may reach out to attorneys Joseph E. Levi or Ed Korsinsky via email or phone. Their information is readily available for inquiry, promising a collaborative approach to aiding aggrieved investors.

Why Choose Levi & Korsinsky?

With over two decades of experience, Levi & Korsinsky has an extensive track record of representing shareholders in significant securities litigation. The firm prides itself on having helped recover hundreds of millions of dollars for its clients, standing out as one of the premier securities litigation firms in the United States, as recognized in various reports. Their commitment is not only evident through results; they also bring a dedicated team of professionals to ensure that all clients receive the best possible legal counsel.

Conclusion

As the October 25, 2025 deadline approaches, it is crucial for LifeMD, Inc. investors who believe they may have been wronged to act promptly. Whether reaching out to the firm only for information or deciding to take legal action, understanding one's rights and options is vital. With legal representation from Levi & Korsinsky, investors may find the support needed during this challenging time.